(Q42465840)

1 November 2017

title

The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells (English)

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

1 November 2022

1 reference

P. N. Maton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697548

1 November 2022

E. E. Lack

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697548

1 November 2022

M. J. Collen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697548

1 November 2022

M. J. Cornelius

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697548

1 November 2022

E. David

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697548

1 November 2022

J. D. Gardner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697548

1 November 2022

R. T. Jensen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1697548

1 November 2022

language of work or name

English

0 references

publication date

1 October 1990

1 reference

full work available at URL

1 November 2017

https://api.elsevier.com/content/article/PII:0016508590906114?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

https://api.elsevier.com/content/article/PII:0016508590906114?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

1 November 2022

1 reference

1 November 2017

volume

99

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

943-950

1 reference

Effects of antrectomy or porta-caval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study

1 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Effect of antrum exclusion on endocrine cells of rat stomach

1 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Pathology of the forestomach in rats treated for 1 year with a new histamine H2-receptor antagonist, SK&F 93479 trihydrochloride

1 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

A fine structural characterization of the proliferated endocrine cells in atrophic gastric mucosa

1 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy

1 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Therapy with Omeprazole in Patients With Peptic Ulcerations Resistant to Extended High-Dose Ranitidine Treatment

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Zollinger-Ellison Syndrome: Current Concepts and Management

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome

1 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Histopathological classification of nonantral gastric endocrine growths in man.

1 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Oxyntic mucosa histology in omeprazole-treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome

1 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment

1 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell Populations

1 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome

1 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach

1 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Omeprazole in the treatment of Zollinger-Ellison syndrome: a 4-year international study

1 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study

1 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1

1 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0016-5085(90)90611-4

1 November 2022

Identifiers

0 references

1 reference